Xeris Biopharma Holdings (XERS) EBITDA (2020 - 2026)
Xeris Biopharma Holdings (XERS) posted EBITDA of $9.11 million for Q2 2026, up 9.5% from $8.32 million a year earlier but down 23.2% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) EBITDA (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Xeris Biopharma Holdings was $52.26 million, up 844.7% year-over-year; for FY2025, it came in at $40.45 million.
- In prior years, Xeris Biopharma Holdings' EBITDA was -$18.57 million in FY2024, -$29.48 million in FY2023, -$68.1 million in FY2022 and -$112.28 million in FY2021.
- Quarterly EBITDA has run from a low of -$47.1 million in Q4 2021 to a high of $20.71 million in Q4 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was $11.86 million (Q1 2026), $20.71 million (Q4 2025) and $10.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn | 20.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.83 Mn |
| Jun 30, 2026 | 9.11 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 20.69 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 8.32 Mn |
| Mar 31, 2025 | 779,000.00 |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | -9.08 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -10.61 Mn |
| Dec 31, 2023 | -6.28 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -12.28 Mn |
| Mar 31, 2023 | -9.65 Mn |
| Dec 31, 2022 | -11.60 Mn |
| Sep 30, 2022 | -15.31 Mn |
| Jun 30, 2022 | -15.35 Mn |
| Mar 31, 2022 | -25.82 Mn |
| Dec 31, 2021 | -47.10 Mn |
API Access
Xeris Biopharma Holdings EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();